DM DM, Telemedicine
Conditions
Interventions
Sponsors
Roche
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Age 18-65 2. Has been diagnosed with type 2 diabetes for more than 6 months. 3. Hemoglobin A1C levels were between 7.5-10% within 6 weeks prior to participating in the study. 4. Get Insulin Treatment (either alone or in combination with other oral medications) for at least 3 months
Exclusion criteria
Exclusion criteria: 1. Can't penetrate fingertip sugar 2. There is no mobile phone that supports applications and data transmission via the Internet 3. Unable to communicate with the researcher according to the research plan 4. People with a history of taking other drugs that affect glucose levels within 3 months before participating in the study as follows Steroid, Vitamin C excluding vitamin C from natural or fruit sources, Vitamin E, Bactrim, Hydroxyurea History of diabetic ketoacidosis, hyperglycemic hyperosmolar state in the past 6 months 6. The patient was diagnosed with psychiatric disorders such as depression, bipolar disorder, and schizophrenia. 7. Pregnant or planning to become pregnant within 12 months or breastfeeding 8. Based on the history and clinical manifestations recorded in the medical record Patients with the following chronic diseases Chronic renal failure with a glomerular filtration rate of less than 30 ml/min/1.73 m2, cirrhosis or hepatitis with alanine aminotransferase or aspartate aminotransferase 3 times the upper limit of normal, alcoholism, hypothyroidism with Thyroid values. stimulating hormone greater than 10 uIU/ml, HIV infection, anemia with hemoglobin less than 10 g/dL, iron deficiency, vitamin B12 deficiency, folic acid deficiency, thalassemia, Enzyme Depletion glucose-6-phosphate dehydrogenase, hemolysis and hemoglobin greater than 16 g/dL 9. Have a history of donating blood or received blood in the past 3 months 10. According to medical records, there was uncontrolled diabetic retinopathy or maculopathy. 11. Signs or history of cancer in the 5 years prior to the screening date except for basal cell, squamous cell, and other in situ carcinomas 12. Has a history of major surgery within 90 days or plans to have a major surgery within 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| different of HbA1c 6 months Repeated measure ANOVA | — |
Secondary
| Measure | Time frame |
|---|---|
| Percentage of patients with HbA1c lower than 7% at the end of the study 6 months Percentage,Percentage of patients with a more than 0.5% reduction in HbA1c at the end of the study. 6 months Percentage | — |
Countries
Thailand
Contacts
Public ContactThanyalak Saetang
Chulalongkorn Hospital
Outcome results
None listed